Scott Bizily - 01 Mar 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role: Chief Legal and HR Officer
Signature: /s/ August J. Moretti, Attorney-in-Fact for Scott Bizily
Issuer symbol: FDMT
Transactions as of: 01 Mar 2023
Net transactions value: -$31,218
Form type: 4
Filing time: 03 Mar 2023, 17:16:11 UTC
Previous filing: 14 Feb 2023
Next filing: 25 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FDMT	Common Stock	Options Exercise	$12,169	+1,875	+76%	$6.49	4,357	01 Mar 2023	Direct	F1
transaction	FDMT	Common Stock	Sale	$43,386	-2,248	-52%	$19.30	2,109	01 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FDMT	Stock Option (Right to Buy)	Options Exercise	$0	-1,875	-8.5%	$0.000000	20,250	01 Mar 2023	Common Stock	1,875	$6.49	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2	The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Content

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.